86.22.Z - Specialist medical practice activities
46.46.Z - Wholesale of pharmaceutical goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
66.19.Z - Other activities auxiliary to financial services, except insurance and pension funding
86.90.D - Paramedical activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0 | -0,4 | -1594,3 |
EBITDA | 0,4 | 0,2 | 0,1 | -43,4 |
Short time liabilities | 0,2 | 0,4 | 1,1 | 152,4 |
Equity capital | 0 | 0 | -0,3 | -1192 |
Operating profit (EBIT) | 0,1 | 0,1 | -0,2 | -285,9 |
Assets | 1,3 | 1,3 | 1,6 | 28,1 |
Net profit (loss) | 0 | 0 | -0,4 | -1745,2 |
Cash | 0 | 0 | 0 | 7,1 |
Net income from sale | 3,3 | 4,3 | 4,5 | 4,8 |
Liabilities and provisions for liabilities | 1,3 | 1,3 | 2 | 57,4 |
Working assets | 0,1 | 0,1 | 0,2 | 95 |
Depreciation | 0,3 | 0,1 | 0,4 | 224,8 |
% | % | % | p.p. | |
Profitability of capital | 481,1 | 72,5 | 109,2 | 36,7 |
Equity capital to total assets | 0,6 | 2,3 | -20 | -22,3 |
Gross profit margin | 1,2 | 0,6 | -7,9 | -8,5 |
EBITDA Margin | 13,5 | 5,6 | 3 | -2,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 24 | 35 | 85 | 50 |
Current financial liquidity indicator | 0,1 | |||
Net dept to EBITDA | 4,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane